Healthy Aging Health Center
This article is from the WebMD Feature Archive
Ain't Parenting Grand?
June 4, 2001 -- A few weeks ago 3-year-old Ryan Butts celebrated a major accomplishment: He made a peanut butter sandwich by himself -- with no help from "Mom," who was watching from an arm's length away in their Mountain Home, Ark., kitchen. Geri Butts, 54, says witnessing that culinary feat was a special moment she would have missed if she and her husband David, 49, hadn't decided to become parents to their grandson, Ryan.
According to the U.S. Census Bureau, about 3.9 million American children under the age of 18 live in 2.5 million households headed by grandparents. For about 1.4 million of those children, the only parental figure is a grandparent.
Nonetheless, Butts says many grandparents who find themselves "suddenly parents" are "still in the closet. They don't want to talk about the situation," she says.
Many of these grandparents are still dealing with issues involving their own children, says Butts. In her case, she says simply that Ryan's mother was "not mature enough to take on the responsibilities of being a mother." Geri and David have raised Ryan since he was 2 months old and have legal custody of the boy.
Resources Are Out There
Butts says she and other local "grand" parents now meet in a support group formed by the Baxter County Family Resource Center. Among the benefits offered by the support group is information sharing on about how to qualify for programs such as WIC or Medicaid, which may help with food and healthcare costs.
Probably one of the best resources for grandparents raising grandchildren is the AARP's Grandparent Information Center. Started in 1993, the center is run by Margaret Hollidge, who describes herself as "a grandmother who 'got stuck' with the sweetest, smartest grandson for 5 years."
In Hollidge's case, she headed a multigenerational household. "My 22-year-old daughter was pregnant and I found myself becoming a co-parent of her child," she says.
Hollidge's daughter and grandson are now on their own, she says, "but we are still very close and when my grandson comes to visit me for a weekend, he says, 'Gran, it is so nice to be home.' "
Difficult Issues to Deal With
Sister Elizabeth Mullane, director of positive caring services and medical services at St. Vincent's Services in New York, often grapples with the more the difficult aspects of grandparents as parents.
Many times a grandparent takes over parenting when "the parents cannot take on their responsibility because of a substance abuse problem or because [they] are in jail," she says. And in such cases, the grandparents are very likely to feel overwhelmed.
"Probably the most important service that we can then offer to both the grandparent and the grandchild is respite care," she says -- that is, short term, temporary care of the child to give the grandparent a break from the daily routine of caregiving. "Even taking over for a few hours can be a welcome and essential relief," she says.
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL full prescribing information.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


